Catalyst Funds Management’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,000	Closed	-$63.3K	–	1248
2024 Q3	$63.3K	Sell	1,000 -2,900	-74%	-$184K	0.01%	687
2024 Q2	$207K	Sell	3,900 -2,200	-36%	-$117K	0.06%	203
2024 Q1	$500K	Buy	+6,100	New	+$500K	0.14%	132